AI Post — Artificial Intelligence

Gemini is now integrated into Docs, Sheets, Slides, and Drive, thus becoming part of a unified workflow. @aipost🏴

⚠️NVIDIA CEO Jensen Huang warns: 2025–2030 could be the last chance for regular people to build generational wealth from AI. Jensen Huang says the AI boom could create huge wealth in the next few years, but once the infrastructure is fully built, breaking into the industry may become far harder. The current wave may be one of the last big entry points for outsiders. He has also argued that skilled trades like electricians, plumbers, and mechanics could become increasingly valuable in an AI-driven economy, since physical work in the real world is far harder to automate than many white-collar jobs. The broader idea: as AI reshapes the economy, some knowledge jobs may change dramatically, while hands-on skills and technical trades could see renewed demand. The future workforce may look very different from today. @aipost🏴

America ranks 20th in per capita AI adoption @aipost🏴

🔥Truly impressive. Figure AI showed their humanoid robot Helix 02 cleaning a messy room on a fully autonomous basis, not teleoperated. @aipost🏴

This is a $20 bottlecap-sized OpenClaw bot in your pocket 🔥 @aipost🏴

🇨🇳China is adopting tech at an absolute breakneck pace. A ridiculous amount of people turned up into a public event in Shenzhen today to install the OpenClaw. Some devs who work at Chinese big tech companies threw a free public event right outside the Tencent Building in Shenzhen. To help regular people get OpenClaw running on their system. @aipost🏴

Chinese AI studios are now creating full TV show series using Seedance 2. Source. @aipost🏴

What did it say 😳 ~ fatherphi @aipost🏴

OpenAI launched a Free AI Academy. 🎓 11 courses to level up: → Prompt engineering → Reasoning with ChatGPT → Data analysis → Coding, writing, search and more. Great for beginners and curious tinkerers! 🔥 Check it out here. @aipost🏴

🗣Palantir's co-founder just told the world what no one in Silicon Valley wants to hear. It's not about AI replacing engineers, it's about AI exposing which software companies were never real to begin with. Joe Lonsdale says low end SaaS is finished. The ones that cost more to sell than they did to build are done. "There's a lot of stuff PE bought, didn't take that much to build, probably put more money into sales than tech. That stuff is in trouble." But here's the twist. When people say they "vibe coded Palantir" in a weekend, Lonsdale laughs. A company that took hundreds of millions and the best engineers on the planet to build is not getting replaced by a chatbot prompt. The real story is what's hiding underneath. 20-25% of the $3 trillion private credit market is SaaS companies. UBS says default rates could hit 13% if AI disruption accelerates. That's 3x the projected high-yield default rate. PE-backed software deals already dropped 21% last year. Firms can't figure out how to price the risk of AI making their portfolio companies obsolete. The software that runs on real engineering, proprietary data, and regulatory moats will survive. The software that runs on sales decks and inflated multiples won't. AI didn't come for the engineers, it simply came for the pretenders. @aipost🏴

Global AI usage is splintering into three distinct camps @aipost🏴

⚠️Most people have no idea where we're going We're barely 3 months into 2026 and we've got: - First human trial reversing cellular age via epigenetic reprogramming (ER-100 launched Q1) - Psychedelics crushing Phase III - Compass hit endpoint for psilocybin in treatment-resistant depression - South Korea reprogramming colon cancer cells back to normal (published Jan 22, announced Feb 5) - Spain's pancreatic cancer triple-drug combo crowdfunding €2.5M in 72hrs for human trials - China NDV-GT engineered virus hitting 90% disease control in Phase 1 advanced cancer patients - Turkey eliminating glioblastoma in mice - all survived 250+ days (breakthrough published early 2026) - FDA granting Breakthrough Device Designation for rapid drug-resistant pathogen tests (Feb 18) - biotech IPOs thawing after multi-year freeze - $1B raised in one week - FDA deciding on first-of-its-kind gene therapy for Hunter syndrome (decision expected Feb 2026) - CAR-T therapy now targeting aging gut cells to boost regeneration Biotech will define this decade. @aipost🏴